Report: Price for blindness gene therapy Luxturna is ‘four times too high’ at $850000 – Genetic Literacy Project
Genetic Literacy Project |
Report: Price for blindness gene therapy Luxturna is 'four times too high' at $850000
Genetic Literacy Project The report from the Institute for Clinical and Economic Review focused on the medicine Luxturna, the first-of-its-kind gene therapy approved for the U.S. market and the most expensive medicine by list price. It is the latest flashpoint in the debate … At $850000, price for new childhood blindness gene therapy four times too high, analysis says 6 amazing medical advancements to expect in 2018 Spark Therapeutics: Challenges Posed By Success |
